CHEMIC, LLC – Trademark Portfolio

Entity Type: 16

CHEMIC, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SAFEFX, METALFX, and BROMINOX. The owner is based in BATON ROUGE, LA.

BUILDING G, #127

17732 HIGHLAND ROAD

BATON ROUGE, LA 70810

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BROMINOX
BROMINOX
Registered 2020
SAFEFX
SAFEFX
Registered 2018
METALFX
METALFX
Registered 2018

Trademark Classifications

CHEMIC, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CHEMIC, LLC have?

CHEMIC, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does CHEMIC, LLC file in?

CHEMIC, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CHEMIC, LLC's most well-known trademarks?

CHEMIC, LLC's registered trademark portfolio includes well-known marks such as SAFEFX, METALFX, and BROMINOX. These are among 3 currently registered trademarks in the portfolio.

What is CHEMIC, LLC's trademark registration success rate?

CHEMIC, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.